ERK5-IN-1; 1234479-76-5; XMD8-85; CHEMBL1673039; 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-5,11-dimethyl-; 2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one; 2-[2-methoxy-4-(4-methyl-1-piperazinyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone; 2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; SCHEMBL618262; CHEBI:91375; HMS3295A11; BCP19788; EX-A3073; BDBM50337127; ZB1553; ZINC66066276; ERK5-IN-1 XMD 8-85; CS-4938; XMD17-109 (ERK5-IN-1); AC-36310; BS-14786; HY-14403; A16232; D71039; A920606; BRD-K64857848-001-01-5; Q27163240; 2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5,11-dimethyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one; 2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one; 2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one; 6H-?Pyrimido[4,?5-?b]?[1,?4]?benzodiazepin-?6-?one, 5,?11-?dihydro-?2-?[[2-?methoxy-?4-?(4-?methyl-?1-?piperazinyl)?phenyl]?amino]?-?5,?11-?dimethyl-; 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one,5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-5,11-dimethyl-; X7Y